Samama M - Search Results

1

Small abnormal echos after mitral valve replacement with bileaflet mechanical prostheses: predisposing factors and effect on thromboembolism.

Iung B, Cormier B, Dadez E, Drissi MF, Tsezana R, Viguier E, Caviezel B, Michel PL, Samama M, Vahanian A, et al. Iung B, et al. Among authors: samama m. J Heart Valve Dis. 1993 May;2(3):259-66. J Heart Valve Dis. 1993. PMID: 8269117

2

AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves.

Acar J, Iung B, Boissel JP, Samama MM, Michel PL, Teppe JP, Pony JC, Breton HL, Thomas D, Isnard R, de Gevigney G, Viguier E, Sfihi A, Hanania G, Ghannem M, Mirode A, Nemoz C. Acar J, et al. Among authors: samama mm. Circulation. 1996 Nov 1;94(9):2107-12. doi: 10.1161/01.cir.94.9.2107. Circulation. 1996. PMID: 8901659 Clinical Trial.

3

[Hemorrhagic risk in intravenously administered thrombolytic treatment in acute myocardial infarction].

Acar J, Dorent R, Vahanian A, Michel PL, Cormier B, Slama M, Cazaux P, Conard J, Verdy E, Samama M. Acar J, et al. Among authors: samama m. Arch Mal Coeur Vaiss. 1988 May;81 Spec No:59-65. Arch Mal Coeur Vaiss. 1988. PMID: 3142430 Clinical Trial. French.

4

[Actilyse: biological aspects].

Samama M, Cormier B, Conard J. Samama M, et al. Arch Mal Coeur Vaiss. 1988 May;81 Spec No:51-7. Arch Mal Coeur Vaiss. 1988. PMID: 3142427 Review. French.

5

Comparison of thrombolytic, fibrinolytic, and fibrinogenolytic properties of tissue plasminogen activator, streptokinase, single-chain urokinase, high molecular weight and low molecular weight urokinase in human plasma in vitro.

Samama M, Nguyen G, Desnoyers P, Lourenco DM, Fretault J, Horellou MH, Conard J, Szwarcer E, Verdy E, Vahanian A. Samama M, et al. Fundam Clin Pharmacol. 1988;2(6):509-23. doi: 10.1111/j.1472-8206.1988.tb00652.x. Fundam Clin Pharmacol. 1988. PMID: 3149257

6

[Thrombolytic treatment in the acute phase of myocardial infarction. Evaluation in 1986].

Kher A, Michel PL, Samama M, Acar J. Kher A, et al. Among authors: samama m. Ann Med Interne (Paris). 1986;137(7):584-9. Ann Med Interne (Paris). 1986. PMID: 3545003 Review. French.

7

[Tissue plasminogen activator (t-PA) in myocardial infarction. Biological aspects].

Samama M, Verdy E, Conard J, Vahanian A, Michel P, Van Dreden P, Nguyen G, Horellou MH, Combrisson A, Acar J. Samama M, et al. Arch Mal Coeur Vaiss. 1986 Oct;79(11):1618-24. Arch Mal Coeur Vaiss. 1986. PMID: 3103572 Clinical Trial. French.

8

Prevention of thromboembolic disease in general surgery with clexane (enoxaparin).

Combe S, Samama MM. Combe S, et al. Among authors: samama mm. Semin Thromb Hemost. 1991;17 Suppl 3:291-5. Semin Thromb Hemost. 1991. PMID: 1661438 Clinical Trial. No abstract available.

9

Low molecular weight heparin compared with unfractionated heparin in prevention of postoperative thrombosis.

Samama M, Bernard P, Bonnardot JP, Combe-Tamzali S, Lanson Y, Tissot E. Samama M, et al. Br J Surg. 1988 Feb;75(2):128-31. doi: 10.1002/bjs.1800750213. Br J Surg. 1988. PMID: 2832030 Clinical Trial.

10

Prevention of postoperative thromboembolism in general surgery with enoxaparin.

Samama MM. Samama MM. Eur J Surg Suppl. 1994;(571):31-3. Eur J Surg Suppl. 1994. PMID: 7519086 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

754 results

Search Page

Filters